Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Giuseppe Mele"'
Autor:
Antonella Bruzzese, Daniele Derudas, Monica Galli, Enrica Antonia Martino, Stefano Rocco, Concetta Conticello, Catello Califano, Nicola Giuliani, Silvia Mangiacavalli, Giuliana Farina, Alessandra Lombardo, Marino Brunori, Elena Rossi, Elisabetta Antonioli, Roberto Ria, Renato Zambello, Nicola Di Renzo, Giuseppe Mele, Gianpaolo Marcacci, Giuseppe Pietrantuono, Gaetano Palumbo, Nicola Cascavilla, Claudio Cerchione, Angelo Belotti, Clelia Criscuolo, Giuseppina Uccello, Paola Curci, Ernesto Vigna, Francesco Mendicino, Enrico Iaccino, Selena Mimmi, Cirino Botta, Donatella Vincelli, Nicola Sgherza, Angela Bonalumi, Luca Cupelli, Raffaella Stocchi, Massimo Martino, Stelvio Ballanti, Dominella Gangemi, Alfredo Gagliardi, Barbara Gamberi, Alessandra Pompa, Giovanni Tripepi, Ferdinando Frigeri, Ugo Consoli, Sara Bringhen, Elena Zamagni, Francesca Patriarca, Valerio De Stefano, Francesco Di Raimondo, Salvatore Palmieri, Maria Teresa Petrucci, Massimo Offidani, Pellegrino Musto, Mario Boccadoro, Michele Cavo, Antonino Neri, Fortunato Morabito, Massimo Gentile
Publikováno v:
Hematological Oncology. 40:704-715
The combination of elotuzumab, lenalidomide, and dexamethasone (EloRd) enhanced the clinical benefit over Rd with a manageable toxicity profile in the ELOQUENT-2 trial, leading to its approval in relapsed/refractory multiple myeloma (RRMM). The prese
Autor:
Enrica Antonia Martino, Concetta Conticello, Elena Zamagni, Vincenzo Pavone, Salvatore Palmieri, Maurizio Musso, Paola Tacchetti, Anna Mele, Lucio Catalano, Ernesto Vigna, Antonella Bruzzese, Francesco Mendicino, Cirino Botta, Iolanda Donatella Vincelli, Giuliana Farina, Marialucia Barone, Clotilde Cangialosi, Katia Mancuso, Ilaria Rizziello, Serena Rocchi, Antonietta Pia Falcone, Giuseppe Mele, Giovanni Reddiconto, Bruno Garibaldi, Enrico Iaccino, Giovanni Tripepi, Barbara Gamberi, Francesco Di Raimondo, Pellegrino Musto, Antonino Neri, Michele Cavo, Fortunato Morabito, Massimo Gentile
Publikováno v:
Hematological oncologyREFERENCES. 40(5)
In combination with lenalidomide and dexamethasone (KRd), Carfilzomib has been approved for the treatment of relapsed and refractory multiple myeloma (RRMM) on ASPIRE trial. Efficacy and safety of the triplet are still the object of investigation by
Autor:
Valerio De Stefano, Lucio Catalano, Lucia Pantani, Pellegrino Musto, Elena Rossi, Enrica Antonia Martino, Antonetta Pia Falcone, Ernesto Vigna, Iolanda Vincelli, Salvatore Palmieri, Paola Tacchetti, Fortunato Morabito, Sara Bringhen, Giovanni Tripepi, Maria Teresa Petrucci, Serena Rocchi, Bruno Garibaldi, Vincenzo Pavone, Francesco Di Raimondo, Giuliana Farina, Nicola Cascavilla, Monica Galli, Antonino Neri, Stelvio Ballanti, Silvia Mangiacavalli, Maurizio Musso, Ilaria Rizzello, Ferdinando Frigeri, Massimo Offidani, Clotilde Cangialosi, Massimo Gentile, Antonella Bruzzese, Elena Zamagni, Anna Mele, Cirino Botta, Mario Boccadoro, Daniele Derudas, Marialucia Barone, Nicola Di Renzo, Concetta Conticello, Giovanni Reddiconto, Roberto Ria, Michele Cavo, Giuseppe Mele
The lack of a randomized trial comparing carfilzomib (K) versus elotuzumab (Elo) associated with lenalidomide and dexamethasone (Rd) prompted us to assess the relative usefulness of one triplet over the other. Five independent retrospective cohorts o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63023416c48907a833c628edda117e47
http://hdl.handle.net/10447/523198
http://hdl.handle.net/10447/523198
Autor:
Anna Mele, Attilio Guarini, Nicola Cascavilla, Rita Rizzi, Sabrina Sabatelli, E. Prete, Maria Rosaria Morciano, Patrizio Mazza, Antonietta Falcone, Lorenzo Tonialini, Domenico Pastore, Carolina Vergine, Massimo Offidani, Silvia Sibilla, Rosa De Francesco, Giuseppe Tarantini, Vincenzo Pavone, Giuseppe Mele, Giuseppina Greco, Angela Giannotta, Giorgina Specchia, Gaetano Palumbo, Silvana Capalbo, Stefania Citiso, Clara De Risi, Nicola Di Renzo, Giulia Palazzo, Giovanni Reddiconto, Paola Curci, Grazia Sanpaolo, Antonino Greco, Candida Germano, R. Miccolis
Publikováno v:
Annals of hematology. 100(2)
Carfilzomib, lenalidomide, and dexamethasone (KRd) have been approved for the treatment of relapsed and refractory multiple myeloma (RRMM) based on ASPIRE clinical trial. However, its effectiveness and safety profile in real clinical practice should
Autor:
Maria Giulia Lionetto, Iolanda Pio, F. Piras, E. De Dominicis, Domenico Santoro, Roberto Caricato, Giuseppe Mele, Elisa Gritti, Oronzo Santoro, Tiziano Pastore
A comprehensive pilot study was carried out to experimentally assess the potential of newly developed treatment trains integrating two-stage AOPs and biofiltration to reach potable reuse water quality standards from municipal wastewater. The processe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8de06f232ea038bb8c8ff974a2105691
https://hdl.handle.net/11587/434597
https://hdl.handle.net/11587/434597
Autor:
Domenico Pastore, Giuseppe Mele
Publikováno v:
Case Reports in Hematology
Case Reports in Hematology, Vol 2018 (2018)
Case Reports in Hematology, Vol 2018 (2018)
EMD of myeloma usually occurs several years after diagnosis and is associated with a very poor OS of λMM with extramedullary intracranial soft-tissue relapsed after VTD-PACE followed by ASCT. The salvage program with KRd regimen determines a second
Autor:
Jorge J. Castillo, Anna Waszczuk-Gajda, Artur Jurczyszyn, Agnieszka Barchnicka, Jacek Czepiel, Davila Julio Valls, Sebastian Grosicki, Edvan de Queiroz Crusoe, Joanna Gdula-Argasińska, Vania Hungria, Alessandro Gozzetti, Marcin Ksieniewicz, Massimo Gentile, David H. Vesole, Ravi Vij, Mark A. Fiala, Giuseppe Mele, Krzysztof Mądry
Multiple myeloma is a plasma cell malignancy characterized by clonal proliferation of plasma cells in the bone marrow and associated organ damage. Usually, patients with myeloma present with a single monoclonal protein in serum and/or urine constitut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36a0337a2403a3ebd17b1af6ae56b264
http://hdl.handle.net/11365/1063217
http://hdl.handle.net/11365/1063217
Autor:
Pierre Basílio Almeida Fechine, Luigi Carbone, Otília Deusdênia L. Pessoa, Maria Elenir Nobre Pinho Ribeiro, Giuseppe Mele, Selma Elaine Mazzetto, Juliano C. Denardin, A. C. H. Barreto, Tamara Gonçalves, Igor Marques Cavalcante, Nágila M.P.S. Ricardo, Telma L. G. Lemos, Vivian Romero Santiago, Rafael M. Freire
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 14; Issue 9; Pages: 18269-18283
International journal of molecular sciences (Online) 14 (2013): 18269–18283. doi:10.3390/ijms140918269
info:cnr-pdr/source/autori:Barreto, Antonio C. H.; Santiago, Vivian R.; Freire, Rafael M.; Mazzetto, Selma E.; Denardin, Juliano C.; Mele, Giuseppe; Cavalcante, Igor M.; Ribeiro, Maria E. N. P.; Ricardo, Nagila M. P. S.; Goncalves, Tamara; Carbone, Luigi; Lemos, Telma L. G.; Pessoa, Otilia D. L.; Fechine, Pierre B. A./titolo:Magnetic Nanosystem for Cancer Therapy Using Oncocalyxone A, an Antitomour Secondary Metabolite Isolated from a Brazilian Plant/doi:10.3390%2Fijms140918269/rivista:International journal of molecular sciences (Online)/anno:2013/pagina_da:18269/pagina_a:18283/intervallo_pagine:18269–18283/volume:14
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
International Journal of Molecular Sciences, Vol 14, Iss 9, Pp 18269-18283 (2013)
International Journal of Molecular Sciences; Volume 14; Issue 9; Pages: 18269-18283
International journal of molecular sciences (Online) 14 (2013): 18269–18283. doi:10.3390/ijms140918269
info:cnr-pdr/source/autori:Barreto, Antonio C. H.; Santiago, Vivian R.; Freire, Rafael M.; Mazzetto, Selma E.; Denardin, Juliano C.; Mele, Giuseppe; Cavalcante, Igor M.; Ribeiro, Maria E. N. P.; Ricardo, Nagila M. P. S.; Goncalves, Tamara; Carbone, Luigi; Lemos, Telma L. G.; Pessoa, Otilia D. L.; Fechine, Pierre B. A./titolo:Magnetic Nanosystem for Cancer Therapy Using Oncocalyxone A, an Antitomour Secondary Metabolite Isolated from a Brazilian Plant/doi:10.3390%2Fijms140918269/rivista:International journal of molecular sciences (Online)/anno:2013/pagina_da:18269/pagina_a:18283/intervallo_pagine:18269–18283/volume:14
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
International Journal of Molecular Sciences, Vol 14, Iss 9, Pp 18269-18283 (2013)
This paper describes the investigation and development of a novel magnetic drug delivery nanosystem (labeled as MO-20) for cancer therapy. The drug employed was oncocalyxone A (onco A), which was isolated from Auxemma oncocalyx, an endemic Brazilian
Autor:
Maria Rosaria Coppi, Marilena Greco, Angela Melpignano, Salvatore Mauro, Giuseppe Mele, Gianni Quarta, Giacomo Loseto
Publikováno v:
Case Reports in Hematology, Vol 2013 (2013)
Case Reports in Hematology
Case Reports in Hematology
Second cancers and particularly postransplant lymphoproliferative disorders (PTLDs) are extremely rare in patients undergoing autologous peripheral blood stem cell transplantation (auto-SCT). We report the case of clonally rearranged T-cell expansion
Publikováno v:
ChemInform. 43
Cardanol is a renewable, low cost natural material, widely available as a by-product of the cashew industry. It is a mixture of 3-n-pentadecylphenol, 3-(pentadeca-8-enyl)phenol, 3-(pentadeca-8,11-dienyl)phenol and 3-(pentadeca-8,11,14-trienyl)phenol.